Neuro-Oncology Reviews
Volume
24 Number 6
31 March 2022
Home > Publications > Neuro-Oncology Reviews > Volume 24, Year 2022 > Number 6, 31 March
Altinoz
MA, Ozpinar A, Hacker E, Ozpinar A.
A
hypothetical proposal to employ
meperidine
and tamoxifen in treatment of glioblastoma. Role of
P-glycoprotein,
ceramide
and metabolic pathways.
Clin
Neurol Neurosurg. 2022 Mar 16;215:107208→.
doi: 10.1016/j.clineuro.2022.107208→.
PMID: 35316699→.
Review˰ ˍ
Gader
G, Badri M, Guediche S, Rkhami M, Zammel I.
Cerbellar
medulloblastoma
in
the elderly: Case report and review of the literature.
Int
J Surg Case Rep. 2022 Mar 16;93:106949→.
doi: 10.1016/j.ijscr.2022.106949→.
PMID: 35313184→.
Case report, Review.
ˍ
Komarasamy
TV, Adnan NAA, James W, Balasubramaniam VRMT.
Zika
Virus
Neuropathogenesis:
The Different Brain Cells, Host Factors and Mechanisms
Involved.
Front
Immunol. 2022 Mar 16;13:773191→.
doi: 10.3389/fimmu.2022.773191→.
PMID: 35371036→.
Review. ˍ
Kumar
M, Nanga RPR, Verma G, Wilson N, Brisset JC, Nath K, Chawla
S.
Emerging
MR
Imaging and Spectroscopic Methods to Study Brain Tumor
Metabolism.
Front
Neurol. 2022 Mar 16;13:789355→.
doi: 10.3389/fneur.2022.789355→.
PMID: 35370872→.
Review. ˍ
Edmonston
D, Vanderwalde N, Ballo M.
Hypofractionation
in Older Adults With
Glioblastoma.
Semin
Radiat Oncol. 2022 Mar 17;32(2):168-171→.
doi: 10.1016/j.semradonc.2021.11.007→.
PMID: 35307119→.
Review. ˍ
*
Reiter RJ, Sharma R, Rosales-Corral S, de Mange J, Phillips WT,
Tan DX, Bitar RD.
Melatonin in
ventricular and subarachnoid cerebrospinal fluid: Its function in
the neural glymphatic network and biological significance for
neurocognitive health.
Biochem
Biophys Res Commun. 2022 Mar 17;605:70-81→.
doi: 10.1016/j.bbrc.2022.03.025→.
PMID: 35316766→.
Review˰
ˍ
Govindarajan
V, Shah AH, Di L, Rivas S, Suter R, Eichberg DG, Luther E, Lu V,
Morell AA, Ivan ME, Komotar RJ, Ayad N, De La Fuente M.
Systematic
Review of
Epigenetic
Therapies for Treatment of IDH-mutant Glioma.
World
Neurosurg. 2022 Mar 18:S1878-8750(22)00341-2→.
doi: 10.1016/j.wneu.2022.03.051→.
PMID: 35314408→.
Review˰ ˍ
*
Miao
L, Zhang J, Zhang Z, Wang S, Tang F, Teng M, Li Y.
A
Bibliometric and
Knowledge-Map
Analysis of CAR-T Cells From 2009 to 2021.
Front
Immunol. 2022 Mar 18;13:840956→.
doi: 10.3389/fimmu.2022.840956→.
PMID: 35371087→.
Bibliometric analysis. ˍ
Trezza
A, de Laurentis C, Biassoni V, Carrabba GG, Schiavello E, Canonico
F, Remida P, Moretto A, Massimino M, Giussani C.
Cervicomedullary
gliomas in
pediatric
age: a review of the literature and tertiary care center
experience.
Pediatr
Neurosurg. 2022 Mar 18→.
doi: 10.1159/000524165→.
PMID: 35306489→.
Review. ˍ
Valério
E, Alves de Castro JV, Carraro DM, Torrezan GT, Kulikowski LD,
Costa FD.
Beyond
Midline: Diffuse Hemispheric Glioma, H3 K27M-Mutant with
Aggressive
Behavior.
J
Neuropathol Exp Neurol. 2022 Mar 18:nlac016→.
doi: 10.1093/jnen/nlac016→.
PMID: 35303099→.
Letter to the Editor. ˍ
Vuong
HG, Ngo TNM, Le HT, Jea A, Hrachova M, Battiste J, McNall-Knapp R,
Dunn IF.
Prognostic
Implication of Patient Age in H3K27M-Mutant Midline Gliomas.
Front
Oncol. 2022 Mar 18;12:858148→.
doi: 10.3389/fonc.2022.858148→.
PMID: 35371982→.
Meta-analysis. ˍ
*
Ozbek
MA, Yardibi F, Genç B, Basak AT, Tahta A, Akalan
N.
Pediatric
brain tumors:
a bibliometric analysis.
Childs
Nerv Syst. 2022 Mar 19→.
doi: 10.1007/s00381-022-05506-7→.
PMID: 35306574→.
Bibliometric analysis˰ ˍ
Persano
F, Gigli G, Leporatti S.
Natural
Compounds as Promising Adjuvant
Agents
in The Treatment of Gliomas.
Int
J Mol Sci. 2022 Mar 20;23(6):3360→.
doi: 10.3390/ijms23063360→.
PMID: 35328780→.
Review. ˍ
Abdelsayed
N, Bondranko Z, Montesano P.
Schwannomatosis
Presenting With a
Grade
IV Glioblastoma: A Case Report and Literature Review.
Cureus.
2022 Mar 22;14(3):e23381→.
doi: 10.7759/cureus.23381→.
PMID: 35475061→.
Case report, Review. ˍ
Komori
T.
The
2021 WHO classification of tumors, 5th edition, central nervous
system
tumors: the 10 basic principles.
Brain
Tumor Pathol. 2022 Mar 22→.
doi: 10.1007/s10014-022-00428-3→.
PMID: 35316415→.
Editorial. ˍ
Lo
Greco MC, Milazzotto R, Liardo RLE, Acquaviva G, La Rocca M,
Altieri R, Certo F, Barbagallo GM, Basile A, Foti PV, Palmucci S,
Pergolizzi S, Pontoriero A, Spatola C.
Relapsing
High-Grade Glioma from Peritumoral Zone: Critical Review
of
Radiotherapy Treatment Options.
Brain
Sci. 2022 Mar 22;12(4):416→.
doi: 10.3390/brainsci12040416→.
PMID: 35447948→.
Review. ˍ
*
Perlow
HK, Prasad RN, Yang M, Klamer B, Matsui J, Marrazzo L, Detti B,
Scorsetti M, Clerici E, Arnett A, Beyer S, Ammirati M, Chakravarti
A, Raval RR, Brown PD, Navarria P, Scoccianti S, Grecula JC,
Palmer JD.
Accelerated
hypofractionated
radiation for elderly or frail patients with a newly diagnosed
glioblastoma:
A pooled analysis of patient-level data from 4 prospective
trials.
Cancer.
2022 Mar 22→.
doi: 10.1002/cncr.34192→.
PMID: 35315512→.
Pooled analysis˰ ˍ
Knecht
KT, Stockert AL.
Editorial:
Complementary and Alternative Medicine Use
in
Cancer Patients.
Front
Nutr. 2022 Mar 23;9:875937→.
doi: 10.3389/fnut.2022.875937→.
PMID: 35399677→.
Editorial. ˍ
Lechpammer
M, Rao R, Shah S, Mirheydari M, Bhattacharya D, Koehler A, Toukam
DK, Haworth KJ, Pomeranz Krummel D, Sengupta S.
Advances
in Immunotherapy for
the
Treatment of Adult Glioblastoma: Overcoming Chemical and Physical
Barriers.
Cancers
(Basel). 2022 Mar 23;14(7):1627→.
doi: 10.3390/cancers14071627→.
PMID: 35406398→.
Review. ˍ
Wahyuhadi
J, Immadoel Haq IB, Arifianto MR, Sulistyono B, Meizikri R, Rosada
A, Sigit Prakoeswa CR, Susilo RI.
Active
Immunotherapy for Glioblastoma Treatment: A Systematic Review and
Meta-Analysis.
Cancer
Control. 2022 Mar 23, 2022;29:10732748221079474→.
doi: 10.1177/10732748221079474→.
PMID: 36748348→.
Review, Meta-analysis. ˍ
Wolfgang
G.
The
growing importance of neuro-oncology for neurologists.
Neurol
Sci. 2022 Mar 23→.
doi: 10.1007/s10072-022-06002-1→.
PMID: 35320439→.
Editorial. ˍ
Peeri
H, Koltai H.
Cannabis
Biomolecule Effects on Cancer Cells and Cancer
Stem
Cells: Cytotoxic, Anti-Proliferative, and Anti-Migratory
Activities.
Biomolecules.
2022 Mar 24;12(4):491→.
doi: 10.3390/biom12040491→.
PMID: 35454080→.
Review. ˍ
Pritha
A, Anderson R, Anderson DE, Nicolaides T.
A
Holistic Review on the
Current
and Future Status of Biology-Driven and Broad-Spectrum Therapeutic
Options
for Medulloblastoma.
Cureus.
2022 Mar 24;14(3):e23447→.
doi: 10.7759/cureus.23447→.
PMID: 35481313→.
Review. ˍ
Mian
SY, Nambiar A, Kaliaperumal C.
Phytotherapy
for the Treatment of
Glioblastoma:
A Review.
Front
Surg. 2022 Mar 25;9:844993→.
doi: 10.3389/fsurg.2022.844993→.
PMID: 35402495→.
Review. ˍ
Yuan
B, Wang G, Tang X, Tong A, Zhou L.
Immunotherapy
of glioblastoma: recent
advances
and future prospects.
Hum
Vaccin Immunother. 2022 Mar 28:1-16→.
doi: 10.1080/21645515.2022.2055417→.
PMID: 35344682→.
Review. ˍ
*
Bauman
MMJ, Harrison DJ, Giesken MB, Daniels DJ.
The
evolving landscape of
pilocytic
astrocytoma: a bibliometric analysis of the top-100 most cited
publications.
Childs
Nerv Syst. 2022 Mar 29→.
doi: 10.1007/s00381-022-05503-w→.
PMID: 35352179→.
Bibliometric analysis˰ ˍ
Santo
G, Laudicella R, Linguanti F, Nappi AG, Abenavoli E, Vergura V,
Rubini G, Sciagrà R, Arnone G, Schillaci O, Minutoli F,
Baldari S, Quartuccio N, Bisdas S.
The
Utility of Conventional Amino Acid PET Radiotracers in the
Evaluation of
Glioma
Recurrence also in Comparison with MRI.
Diagnostics
(Basel). 2022 Mar 29;12(4):844→.
doi: 10.3390/diagnostics12040844→.
PMID: 35453892→.
Review. ˍ
Cohen
KJ et
al., PDQ Pediatric Treatment Editorial Board.
Childhood
Medulloblastoma and Other Central Nervous System Embryonal Tumors
Treatment (PDQ®): Health Professional Version.
PDQ
Cancer Inf Summ.
2022 Mar 30→.
NCBI Bookshelf
ID: NBK65981→.
PMID:
26389418→.
Review.
ˍ
Kumar
M, Nanga RPR, Chawla S.
Editorial:
Structural, Metabolic, and
Physiologic
MR Imaging to Study Glioblastomas.
Front
Neurol. 2022 Mar 30;13:887027→.
doi: 10.3389/fneur.2022.887027→.
PMID: 35432174→.
Editorial. ˍ
*
Ribatti
D, Pezzella F.
Vascular
Co-Option and Other Alternative Modalities of
Growth
of Tumor Vasculature in Glioblastoma.
Front
Oncol. 2022 Mar 30;12:874554→.
doi: 10.3389/fonc.2022.874554→.
PMID: 35433447→.
Review. ˍ
*
Torrisi
F, Alberghina C, D'Aprile S, Pavone AM, Longhitano L, Giallongo S,
Tibullo D, Di Rosa M, Zappalà A, Cammarata FP, Russo G,
Ippolito M, Cuttone G, Li Volti G, Vicario N, Parenti R.
The
Hallmarks of Glioblastoma: Heterogeneity,
Intercellular
Crosstalk and Molecular Signature of Invasiveness and
Progression.
Biomedicines.
2022 Mar 30;10(4):806→.
doi: 10.3390/biomedicines10040806→.
PMID: 35453557→.
Review. ˍ
Zhou
YS, Wang W, Chen N, Wang LC, Huang JB.
Research
progress of anti-glioma
chemotherapeutic
drugs (Review).
Oncol
Rep. 2022 Mar 30;47(5):101→.
doi: 10.3892/or.2022.8312→.
PMID: 35362540→.
Review. ˍ
Boa
Sorte AA Jr, Garcia CC, Neto MR, de Oliveira MF, Rotta JM.
Brain
cryptococcoma
mimicking a glioblastoma in an immunocompetent patient: A rare
case
report and comprehensive review.
Surg
Neurol Int. 2022 Mar 31;13:114→.
doi: 10.25259/SNI_1243_2021→.
PMID: 35509529→.
Review. ˍ
Mitchell
D, Shireman JM, Dey M.
Surgical
Neuro-Oncology: Management of
Glioma.
Neurol
Clin. 2022 Mar 31;2022 May;40(2):437-453→.
doi: 10.1016/j.ncl.2021.11.003→.
PMID: 35465885→.
Review˰ ˍ
Wang
S, Zhang Z, Miao L, Li Y.
Boron
Neutron Capture Therapy: Current Status
and
Challenges.
Front
Oncol. 2022 Mar 31;12:788770→.
doi: 10.3389/fonc.2022.788770→.
PMID: 35433432→.
Review. ˍ